Search results
Duchenne Muscular Dystrophy (DMD) Treatment
Verywell Health via Yahoo News· 3 days agoInsights Into Treatment Advancements Medically reviewed by Nicholas R. Metrus, MDMedically reviewed by Nicholas R. Metrus, MD Duchenne muscular
Duchene scores winner in 2nd OT, Stars advance to Western Conference final with 2-1 win over Avs
FOX 5 San Diego· 3 days agoDENVER (AP) — Matt Duchene took off down the ice, slid on his knees and pumped his right glove....
Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again
Investor's Business Daily· 22 hours agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and ...
How to watch and what to expect in the 2024 Stanley Cup playoffs
Houston Today· 2 hours agoFour teams are left to chase the Stanley Cup in the NHL playoffs, including three division champions...
Matt Duchene’s overtime winner brings poetic end to Stars’ series vs. Avalanche
Dallas Morning News· 3 days agoMatt Duchene had already broken Colorado’s heart once. After requesting a trade from the team that...
European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug
BioPharma Dive via Yahoo Finance· 1 day agoRather than endorse the recommendation of the EMA, the commission called for a new review for...
Dallas Stars Daily Links: Comeback Duchene
Defending Big D· 1 day agoMatt Duchene scored the series-winner against the team that drafted him, and thereby created one of the more striking bits of drama in a Stanley Cup...
Stars align: Duchene 2OT hero after no-goal call
ESPN· 3 days agoMatt Duchene helped put his current team in the Western Conference finals Friday at the expense of the team that drafted him more than a decade ago. An...
Matt Duchene's Revenge Game Thrills NHL Fans as Stars Eliminate MacKinnon, Avalanche
Bleacher Report· 3 days agoThe Dallas Stars are back in the Western Conference Finals thanks to Matt Duchene's double-overtime...
Why Is Dyne Therapeutics Stock Soaring On Monday?
Benzinga via Yahoo Finance· 20 hours agoEarlier this year, Dyne Therapeutics released initial clinical data from both trials. In the ACHIEVE trial, patients in the 5.4 mg/kg Q8W cohort had a...